| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from the issuance of common stock and pre-funded warrants, net | 100,095 | 100,095 |
| Net cash provided by financing activities | 164,722 | 146,843 |
| Increase in cash, cash equivalents and restricted cash | 48,888 | 75,504 |
| Cash and cash equivalents at beginning of period | 89,059 | - |
| Cash and cash equivalents at end of period | 137,947 | - |
Verastem, Inc. (VSTM)
Verastem, Inc. (VSTM)